Agenus Inc / Stock Price
13.62 +1.27 (10.28%)
After hours: 13.88 +0.26 (1.88%)
AGEN(NASDAQ)
May 24, 4:00 PM EDT · Currency in USD · Disclaimer
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
People also ask
Is Agen a good stock to buy?
What is the prediction for Agen stock in 2025?
What is the Nasdaq forecast for Agen?
Who owns Agen stock?
AGEN | Complete Agenus Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Discover real-time Agenus Inc. Common Stock (AGEN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.
People also search for
Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients.
AGEN Agenus Inc. 12,441. $13.62. $1.27. (10.28%). Today. Watchers, 12,441. 52-Wk Low, $4.78. 52-Wk High, $42.60. Market Cap, $286.01M. Volume, 695,430.00 ...
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its ...
Get Agenus Inc (AGEN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases.